Company Data

Salarius Pharmaceuticals

Ticker
SLRX
Current Price
$2.03 -2.4%
Market Cap
$4.6M
Price Target
Refer to Report
Volume
9.7K
52wk Range
$1.7001 - $18
Advanced Market Data

Overview

Salarius Pharmaceuticals Inc is a biotechnology company developing targeted therapies to treat pediatric and other cancers, including advanced solid tumors. Its lead compound Seclidemstat is in clinical development for treating Ewing sarcoma.

Inbox Intel from Channelchek.

Informed investors make more money. And it’s all about timing. Get it when it happens.

By clicking submit you are agreeing to the Terms of Use and Privacy Policy
© 2018-2022 Noble Financial Group, Inc. All Rights Reserved. Channelchek is provided at no cost to be used for information purposes only and not as investment advisement.